Clinical Trial Detail

NCT ID NCT04249947
Title P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Recruitment Recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Poseida Therapeutics, Inc.
Indications

prostate cancer

Therapies

P-PSMA-101 CAR-T cells

Rimiducid

Age Groups: senior adult

No variant requirements are available.